Thomas L. Mindt
Thomas L. Mindt publishes mostly in Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology, on topics such as Radiopharmaceutical Chemistry and Applications, Click Chemistry and Applications and Peptidase Inhibition and Analysis.
- World rank
- #615,622 of 7,710,434 ranked researchers
- Rank in Austria
- #3,940 of 43,330
- Works
- 149
- Citations
- 4.6k
- Citations per work
- 30.7
What does Thomas L. Mindt research?
Thomas L. Mindt's work is mostly in Medicine (42%), Chemistry (19%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6241.7%
- Medicine6241.7%
- Everything else3825.4%
- Physical Sciences3322.2%
- Chemistry2818.7%
- Physics and Astronomy53.5%
- Life Sciences1610.7%
- 1Radiology, Nuclear Medicine and Imaging27% of their works
- 2Organic Chemistry19% of their works
- 3Molecular Biology11% of their works
- 4Oncology10% of their works
- 5Pulmonary and Respiratory Medicine5% of their works
- 6Radiation4% of their works
Research topics
- Radiopharmaceutical Chemistry and Applications
- Click Chemistry and Applications
- Peptidase Inhibition and Analysis
- Chemical Synthesis and Analysis
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Radioactive Decay and Measurement Techniques
- Radioactive element chemistry and processing
Which keywords describe Thomas L. Mindt's research?
The keywords of their largest research topics: PET Imaging, Radiopharmaceuticals, Targeted Therapy, Drug Discovery, Click Chemistry, Copper-Catalyzed Cycloaddition, Fibroblast Activation Protein and Tumor Microenvironment.
- Uranium
- Radionuclide Metrology
- Therapeutic Antibodies
- PET/CT
- Peptide Synthesis
- Tumor Microenvironment
- Copper-Catalyzed Cycloaddition
- Drug Discovery
- Radiopharmaceuticals
- PET Imaging
- Targeted Therapy
- Click Chemistry
- Fibroblast Activation Protein
- Foldamers
- Imaging
- Fc Receptors
- Decay Rates
- Actinides
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- PET Imaging982 topics
- Radiopharmaceuticals661 topic
- Targeted Therapy661 topic
- Drug Discovery642 topics
- Click Chemistry351 topic
- Copper-Catalyzed Cycloaddition351 topic
- Fibroblast Activation Protein321 topic
- Tumor Microenvironment321 topic
- Foldamers291 topic
- Peptide Synthesis291 topic
- Imaging201 topic
- PET/CT201 topic
- Fc Receptors151 topic
- Therapeutic Antibodies151 topic
- Decay Rates121 topic
- Radionuclide Metrology121 topic
- Actinides81 topic
- Uranium81 topic
Where does Thomas L. Mindt work?
Thomas L. Mindt's main affiliation in the publication record is Ludwig Boltzmann Institute Applied Diagnostics, Austria.
How many publications and citations does Thomas L. Mindt have?
OpenAlex counts 149 works and 4,574 citations for Thomas L. Mindt, an h-index of 39, ranking #615,622 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas L. Mindt. Posts are plain text and can be reported.